Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lactate dehydrogenase C | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | lactate dehydrogenase, putative | lactate dehydrogenase C | 332 aa | 307 aa | 29.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.003 | 0 | 0.5 | |
Echinococcus granulosus | lactate dehydrogenase protein | 0.0056 | 1 | 1 |
Toxoplasma gondii | lactate dehydrogenase LDH2 | 0.0056 | 1 | 0.5 |
Onchocerca volvulus | Neuropeptide F receptor homolog | 0.003 | 0 | 0.5 |
Toxoplasma gondii | malate dehydrogenase MDH | 0.0056 | 1 | 0.5 |
Onchocerca volvulus | 0.003 | 0 | 0.5 | |
Toxoplasma gondii | lactate dehydrogenase LDH1 | 0.0056 | 1 | 0.5 |
Echinococcus multilocularis | L lactate dehydrogenase | 0.0034 | 0.1572 | 0.1572 |
Plasmodium vivax | lactate dehydrogenase | 0.0056 | 1 | 0.5 |
Leishmania major | malate dehydrogenase, putative | 0.0056 | 1 | 0.5 |
Onchocerca volvulus | 0.003 | 0 | 0.5 | |
Onchocerca volvulus | 0.003 | 0 | 0.5 | |
Onchocerca volvulus | 0.003 | 0 | 0.5 | |
Onchocerca volvulus | 0.003 | 0 | 0.5 | |
Echinococcus multilocularis | lactate dehydrogenase a | 0.0056 | 1 | 1 |
Onchocerca volvulus | 0.003 | 0 | 0.5 | |
Onchocerca volvulus | 0.003 | 0 | 0.5 | |
Onchocerca volvulus | 0.003 | 0 | 0.5 | |
Echinococcus multilocularis | lactate dehydrogenase protein | 0.0056 | 1 | 1 |
Onchocerca volvulus | 0.003 | 0 | 0.5 | |
Onchocerca volvulus | 0.003 | 0 | 0.5 | |
Wolbachia endosymbiont of Brugia malayi | malate dehydrogenase | 0.0056 | 1 | 0.5 |
Onchocerca volvulus | Dopamine\/Ecdysteroid receptor homolog | 0.003 | 0 | 0.5 |
Onchocerca volvulus | 0.003 | 0 | 0.5 | |
Echinococcus multilocularis | lactate dehydrogenase a | 0.0056 | 1 | 1 |
Plasmodium falciparum | L-lactate dehydrogenase | 0.0056 | 1 | 0.5 |
Schistosoma mansoni | malate dehydrogenase | 0.0056 | 1 | 1 |
Onchocerca volvulus | 0.003 | 0 | 0.5 | |
Echinococcus granulosus | lactate dehydrogenase a | 0.0056 | 1 | 1 |
Schistosoma mansoni | L-lactate dehydrogenase | 0.0056 | 1 | 1 |
Entamoeba histolytica | malate dehydrogenase, putative | 0.0056 | 1 | 0.5 |
Echinococcus granulosus | L lactate dehydrogenase | 0.0034 | 0.1572 | 0.1572 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 1 | 1 |
Echinococcus multilocularis | lactate dehydrogenase a | 0.0056 | 1 | 1 |
Echinococcus granulosus | lactate dehydrogenase a | 0.0056 | 1 | 1 |
Echinococcus granulosus | L lactate dehydrogenase B chain | 0.0056 | 1 | 1 |
Onchocerca volvulus | 0.003 | 0 | 0.5 | |
Plasmodium falciparum | malate dehydrogenase | 0.0056 | 1 | 0.5 |
Onchocerca volvulus | 0.003 | 0 | 0.5 | |
Onchocerca volvulus | 0.003 | 0 | 0.5 | |
Onchocerca volvulus | 0.003 | 0 | 0.5 | |
Echinococcus multilocularis | L lactate dehydrogenase B chain | 0.0056 | 1 | 1 |
Plasmodium vivax | malate dehydrogenase, putative | 0.0056 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.12 uM | Inhibition of LDH-A (unknown origin) by cell based assay | ChEMBL. | 23302067 |
IC50 (binding) | = 0.12 uM | Inhibition of LDHA (unknown origin) | ChEMBL. | 25288186 |
Inhibition (binding) | = 56 % | Inhibition of LDH-A in human Ramos cells assessed as cellular lactate level at 200 uM after 1 hr | ChEMBL. | 23302067 |
Inhibition (binding) | = 68 % | Inhibition of LDH-A in human Ramos cells assessed as cellular lactate level at 200 uM after 4 hrs | ChEMBL. | 23302067 |
Kd (binding) | = 0.019 uM | Binding affinity to human LDH-A by surface plasmon resonance analysis | ChEMBL. | 23302067 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.